At this time we cannot rule out the possibility that some of the HER2-IHC-negative primary breast cancers may actually be false negatives due to the inherent inaccuracy in IHC and FISH techniques and that a more sensitive technology such as CEER would reveal these cancers to have significant levels of HER2 expression. This evidence concerns the gene ERBB2 and cancer.